E S Husebye

Summary

Affiliation: Akademiska sjukhuset
Country: Sweden

Publications

  1. ncbi Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I
    E S Husebye
    Department of Internal Medicine, University Hospital, Uppsala University, Sweden
    J Clin Endocrinol Metab 82:147-50. 1997
  2. ncbi Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I
    G Gebre-Medhin
    Department of Internal Medicine, University Hospital, Uppsala University, Sweden
    FEBS Lett 412:439-45. 1997
  3. ncbi Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen
    F Rorsman
    Department of Internal Medicine, University Hospital, Uppsala University, Sweden
    Proc Natl Acad Sci U S A 92:8626-9. 1995
  4. ncbi Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease
    A Söderbergh
    Department of Clinical Sciences, University Hospital, Uppsala, Sweden
    J Clin Endocrinol Metab 85:460-3. 2000
  5. ncbi Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease
    G Gebre-Medhin
    Departments of Medicine, University Hospital, Uppsala, Sweden
    Clin Endocrinol (Oxf) 52:775-80. 2000
  6. ncbi TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus
    C J A Smith
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Scand J Immunol 73:147-53. 2011

Collaborators

Detail Information

Publications6

  1. ncbi Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I
    E S Husebye
    Department of Internal Medicine, University Hospital, Uppsala University, Sweden
    J Clin Endocrinol Metab 82:147-50. 1997
    ....
  2. ncbi Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I
    G Gebre-Medhin
    Department of Internal Medicine, University Hospital, Uppsala University, Sweden
    FEBS Lett 412:439-45. 1997
    ..Our results show that CYP IA2 and AADC constitute hepatic autoantigens in patients with APS I and that immunoreactivity against CYP IA2 is associated with the presence of AI-CAH...
  3. ncbi Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen
    F Rorsman
    Department of Internal Medicine, University Hospital, Uppsala University, Sweden
    Proc Natl Acad Sci U S A 92:8626-9. 1995
    ..The biological significance of the neurotransmitters produced by the two enzymes in the beta cells remains largely unknown...
  4. ncbi Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease
    A Söderbergh
    Department of Clinical Sciences, University Hospital, Uppsala, Sweden
    J Clin Endocrinol Metab 85:460-3. 2000
    ..Measurement of autoantibodies against AADC should be included in the evaluation of Addison's disease...
  5. ncbi Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease
    G Gebre-Medhin
    Departments of Medicine, University Hospital, Uppsala, Sweden
    Clin Endocrinol (Oxf) 52:775-80. 2000
    ..To define a suitable dose, the effect of oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease (n = 9) was evaluated...
  6. ncbi TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus
    C J A Smith
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Scand J Immunol 73:147-53. 2011
    ..TSGA10 should be considered as an autoantigen in a subset of APS1 patients and also in a minority of SLE patients. No recognizable clinical phenotype could be found to correlate with positive autoantibody reactivity...